{"id":"https://openalex.org/W7202079953","doi":"https://doi.org/10.1007/s13555-026-01884-x","title":"Adherence to CAL/BDP PAD-Cream Influences Treatment Effectiveness and Preference in Scalp Psoriasis Under Real-Life Conditions: Results from the Prospective, Multicenter, Observational PRO-SCALP Study","display_name":"Adherence to CAL/BDP PAD-Cream Influences Treatment Effectiveness and Preference in Scalp Psoriasis Under Real-Life Conditions: Results from the Prospective, Multicenter, Observational PRO-SCALP Study","publication_year":2026,"publication_date":"2026-08-10","ids":{"openalex":"https://openalex.org/W7202079953","doi":"https://doi.org/10.1007/s13555-026-01884-x","pmid":"https://pubmed.ncbi.nlm.nih.gov/42573965","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13558509"},"language":"en","primary_location":{"id":"doi:10.1007/s13555-026-01884-x","doi":"https://doi.org/10.1007/s13555-026-01884-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01884-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01884-x.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01884-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072258821","display_name":"Anthony Bewley","orcid":"https://orcid.org/0000-0003-1195-0290","observed_orcids":["https://orcid.org/0000-0003-1195-0290"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Anthony Bewley","raw_affiliation_strings":["Department of Dermatology, Barts Health NHS Trust and Queen Mary University, London, UK. anthony.bewley@nhs.net"],"raw_orcid":"https://orcid.org/0000-0003-1195-0290","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Barts Health NHS Trust and Queen Mary University, London, UK. anthony.bewley@nhs.net","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I225661044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012738162","display_name":"Andreas Pinter","orcid":"https://orcid.org/0000-0002-1330-1502","observed_orcids":["https://orcid.org/0000-0002-1330-1502"]},"institutions":[{"id":"https://openalex.org/I4210132578","display_name":"University Hospital Frankfurt","ror":"https://ror.org/03f6n9m15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132578"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Pinter","raw_affiliation_strings":["Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt Am Main, Frankfurt Am Main, Germany"],"raw_orcid":"https://orcid.org/0000-0002-1330-1502","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt Am Main, Frankfurt Am Main, Germany","institution_ids":["https://openalex.org/I4210132578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028252915","display_name":"Jos\u00e9 Luis L\u00f3pez-Estebaranz","orcid":"https://orcid.org/0000-0002-8816-1989","observed_orcids":["https://orcid.org/0000-0002-8816-1989"]},"institutions":[{"id":"https://openalex.org/I4210101151","display_name":"Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n","ror":"https://ror.org/01435q086","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101151","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Luis L\u00f3pez Estebaranz","raw_affiliation_strings":["Department of Dermatology, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n, Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0002-8816-1989","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n, Madrid, Spain","institution_ids":["https://openalex.org/I4210101151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067346810","display_name":"Jordi Galv\u00e1n","orcid":"https://orcid.org/0000-0002-2435-2129","observed_orcids":["https://orcid.org/0000-0002-2435-2129"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jordi Galv\u00e1n","raw_affiliation_strings":["Global Medical Affairs Department, Almirall S.A., Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-2435-2129","affiliations":[{"raw_affiliation_string":"Global Medical Affairs Department, Almirall S.A., Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090708450","display_name":"V\u00edctor Sapena","orcid":"https://orcid.org/0000-0003-4379-6486","observed_orcids":["https://orcid.org/0000-0003-4379-6486"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"V\u00edctor Sapena","raw_affiliation_strings":["Global Clinical Statistics Department, Almirall S.A., Sant Feliu de Llobregat, Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-4379-6486","affiliations":[{"raw_affiliation_string":"Global Clinical Statistics Department, Almirall S.A., Sant Feliu de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072760779","display_name":"V. Koscielny","orcid":"https://orcid.org/0009-0004-3314-880X","observed_orcids":["https://orcid.org/0009-0004-3314-880X"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Volker Koscielny","raw_affiliation_strings":["Global Medical Affairs Department, Almirall S.A., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs Department, Almirall S.A., Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5072258821"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I225661044"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":1.9872,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.78421151,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"16","issue":"9","first_page":"4683","last_page":"4703"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/scalp-psoriasis","display_name":"scalp psoriasis","score":0.996999979019165},{"id":"https://openalex.org/keywords/topical-calcipotriol","display_name":"topical calcipotriol","score":0.7829999923706055},{"id":"https://openalex.org/keywords/betamethasone-dipropionate","display_name":"betamethasone dipropionate","score":0.9950000047683716},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.8090000152587891},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.6930000185966492},{"id":"https://openalex.org/keywords/sleep-quality","display_name":"sleep quality","score":0.7699999809265137},{"id":"https://openalex.org/keywords/psychosocial-impact","display_name":"psychosocial impact","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8944000005722046},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.7337999939918518},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7283999919891357},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6570000052452087},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.6269999742507935},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5605999827384949},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.53329998254776},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.5268999934196472},{"id":"https://openalex.org/C14184104","wikidata":"https://www.wikidata.org/wiki/Q1362526","display_name":"Visual analogue scale","level":2,"score":0.47620001435279846},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.45399999618530273},{"id":"https://openalex.org/C2779800615","wikidata":"https://www.wikidata.org/wiki/Q4897349","display_name":"Betamethasone dipropionate","level":3,"score":0.421999990940094},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.39980000257492065},{"id":"https://openalex.org/C2781162121","wikidata":"https://www.wikidata.org/wiki/Q416132","display_name":"Betamethasone","level":2,"score":0.39890000224113464},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.3458000123500824},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3424000144004822},{"id":"https://openalex.org/C2776009542","wikidata":"https://www.wikidata.org/wiki/Q155683","display_name":"Calcipotriol","level":3,"score":0.32100000977516174},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2858000099658966},{"id":"https://openalex.org/C2781249084","wikidata":"https://www.wikidata.org/wiki/Q908656","display_name":"Preference","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2696000039577484},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.2689000070095062}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13555-026-01884-x","doi":"https://doi.org/10.1007/s13555-026-01884-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01884-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01884-x.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13558509","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13558509/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13558509/pdf/13555_2026_Article_1884.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatol Ther (Heidelb)","raw_type":"Text"},{"id":"pmid:42573965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42573965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e73f7e1d7403473f9ad9cb513f2c85f8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/e73f7e1d7403473f9ad9cb513f2c85f8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dermatology and Therapy, Vol 16, Iss 9, Pp 4683-4703 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s13555-026-01884-x","doi":"https://doi.org/10.1007/s13555-026-01884-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01884-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01884-x.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320331744","display_name":"Almirall","ror":"https://ror.org/03qsven24"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202079953.pdf","grobid_xml":"https://content.openalex.org/works/W7202079953.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1556165793","https://openalex.org/W1967382144","https://openalex.org/W1980058783","https://openalex.org/W1982400355","https://openalex.org/W1990128482","https://openalex.org/W2000398006","https://openalex.org/W2017932566","https://openalex.org/W2029548961","https://openalex.org/W2041868737","https://openalex.org/W2046205521","https://openalex.org/W2059803149","https://openalex.org/W2065523538","https://openalex.org/W2075934703","https://openalex.org/W2109607950","https://openalex.org/W2116526448","https://openalex.org/W2131592234","https://openalex.org/W2137884200","https://openalex.org/W2150699345","https://openalex.org/W2154661682","https://openalex.org/W2156811281","https://openalex.org/W2166956380","https://openalex.org/W2288108902","https://openalex.org/W2317828523","https://openalex.org/W2372546246","https://openalex.org/W2402183860","https://openalex.org/W2556105556","https://openalex.org/W2733237180","https://openalex.org/W2804912652","https://openalex.org/W2901418399","https://openalex.org/W2906944548","https://openalex.org/W2924895007","https://openalex.org/W2980436591","https://openalex.org/W2990052704","https://openalex.org/W2990718102","https://openalex.org/W3027305906","https://openalex.org/W3045628073","https://openalex.org/W3154515463","https://openalex.org/W3207397215","https://openalex.org/W3217457985","https://openalex.org/W4213076670","https://openalex.org/W4249397617","https://openalex.org/W4294957777","https://openalex.org/W4312113486","https://openalex.org/W4327546993","https://openalex.org/W4386982887","https://openalex.org/W4391812778","https://openalex.org/W4394917108","https://openalex.org/W4399053034","https://openalex.org/W4401171378","https://openalex.org/W4401907758","https://openalex.org/W4408932684","https://openalex.org/W4410008879","https://openalex.org/W4410469142","https://openalex.org/W7158066489"],"related_works":["https://openalex.org/W4410381916","https://openalex.org/W7158066489","https://openalex.org/W4399053034","https://openalex.org/W7172430777","https://openalex.org/W3046622164","https://openalex.org/W4404455263","https://openalex.org/W7152132785","https://openalex.org/W3169566913","https://openalex.org/W4401247996","https://openalex.org/W2756615787"],"abstract_inverted_index":{"Scalp":[0,141,273,326],"psoriasis":[1,58,327,545],"is":[2,314,328,346,389,414,538],"often":[3,376],"associated":[4,260,297],"with":[5,37,97,261,298,307,448,462,478,492],"poor":[6,379],"adherence":[7,43,68,90,102,151,210,258,292,309,313,464,482,494,550],"to":[8,44,212,293,339,350,363,378,419,423,552],"topical":[9,387],"therapy.":[10],"A":[11,439],"novel":[12,416],"formulation":[13,417],"of":[14,123,140,336,342,367,383,392,518,559,572],"calcipotriol":[15],"and":[16,28,49,52,81,95,128,135,168,172,196,215,220,280,303,398,428,434,457,480,500,505,520,546],"betamethasone":[17,399],"dipropionate":[18],"based":[19],"on":[20,405],"polyaphron":[21,408],"dispersion":[22,409],"(CAL/BDP":[23],"PAD-cream)":[24],"showed":[25,153,452],"improved":[26,249,525],"outcomes":[27,51,319,456],"satisfaction":[29],"in":[30,35,55,62,112,136,156,187,209,218,236,251,320,446,454,460,473,498,516],"the":[31,113,137,157,197,340,344,355,384,390,468,556,565,569],"PRO-SCALP":[32,64],"study,":[33],"particularly":[34],"patients":[36,65,94,108,183,306,361,447,461,477,491],"high":[38,89,101,463,481,493,549],"adherence.":[39],"We":[40],"evaluated":[41],"how":[42],"CAL/BDP":[45,294,412,444,509,536],"PAD-cream":[46,295,413,445,537],"influences":[47],"patients-":[48],"clinicians-reported":[50],"treatment":[53,357,421,455,469,542,561],"preferences":[54],"mild-to-moderate":[56,449],"scalp":[57,158,321,345,450,501,544,573],"under":[59],"real-life":[60],"conditions":[61],"Europe.":[63],"reported":[66,88,100,109,513],"their":[67],"level":[69],"using":[70],"a":[71,213,329,347,394,401,406,415],"visual":[72],"analogue":[73],"scale":[74],"(VAS).":[75],"Outcomes":[76],"were":[77,234,483],"compared":[78],"between":[79],"low-":[80,237],"high-adherence":[82,239],"subgroups.":[83],"Among":[84],"252":[85],"patients,":[86],"59.9%":[87],"(VAS":[91],"80\u2013100).":[92],"Older":[93],"those":[96],"moderate":[98],"disease":[99,331,380],"(both":[103,222],"p":[104,176,223,244],"<":[105,177,190,224,255,285],"0.05).":[106],"High-adherent":[107],"higher":[110,262,503],"scores":[111,174,266],"Treatment":[114],"Satisfaction":[115,130],"Questionnaire":[116,143,265,275],"for":[117,121,316,508,543,568],"Medication":[118],"Version":[119],"9,":[120],"Convenience":[122],"use":[124],"(p":[125,131,144,189,193,201,254,267,277,284],"=":[126,132,145,194,202,245,268,278],"0.0019)":[127],"Global":[129,230],"0.0166)":[133],"domains,":[134],"Psychosocial":[138],"Effects":[139],"Psoriasis":[142,166,274],"0.0004)":[146],"at":[147,226],"week":[148,227],"8.":[149,228],"Both":[150,485],"subgroups":[152,240,253],"significant":[154],"reductions":[155,497],"Worst":[159],"Itch":[160],"Numeric":[161],"Rating":[162],"Scale":[163],"(WI-NRS),":[164],"scalp-modified":[165],"Area":[167],"Severity":[169],"Index":[170],"(S-mPASI),":[171],"Scalpdex":[173,198],"(all":[175],"0.0001":[178],"vs.":[179,238,242],"baseline),":[180],"although":[181],"high-adherent":[182],"achieved":[184],"greater":[185,281,299,506,514],"improvements":[186,453,515],"WI-NRS":[188,221],"0.0001),":[191,286],"S-mPASI":[192,219],"0.0153),":[195],"Symptoms":[199],"domain":[200],"0.001)":[203],"than":[204,436],"low-adherent.":[205],"Each":[206],"10%":[207],"increase":[208],"corresponded":[211],"0.10-":[214],"0.35-point":[216],"reduction":[217],"0.05)":[225],"Scalp-Physician":[229],"Assessment":[231],"success":[232],"rates":[233],"comparable":[235],"(65.0%":[241],"70.5%;":[243],"0.3633).":[246],"Sleep":[247],"quality":[248,335,517],"significantly":[250],"both":[252,528],"0.0001).":[256],"High":[257,291],"was":[259,296],"Patient":[263],"Preference":[264],"0.0012),":[269],"better":[270,553],"Cream":[271],"Usability":[272],"ratings":[276],"0.0455)":[279],"product":[282],"consumption":[283],"despite":[287],"similar":[288,432],"once-a-day":[289],"usage.":[290],"effectiveness,":[300],"satisfaction,":[301,458,504],"preference,":[302],"QoL.":[304],"While":[305],"low":[308,479],"still":[310],"benefited,":[311],"maximizing":[312],"key":[315,557],"optimal":[317],"real-world":[318],"psoriasis.":[322,574],"ClinicalTrials.gov":[323],"identifier":[324],"NCT05811234.":[325],"long-lasting":[330],"that":[332,466,535,548],"greatly":[333],"impairs":[334],"life.":[337],"Due":[338],"presence":[341],"hair,":[343],"hard":[348],"area":[349],"treat.":[351],"Topical":[352],"medicines":[353],"are":[354],"first":[356],"choice.":[358],"However,":[359],"many":[360],"struggle":[362],"follow":[364],"them":[365],"because":[366],"inconvenience,":[368],"cosmetic":[369],"concerns,":[370],"side":[371],"effects,":[372],"or":[373],"dissatisfaction,":[374],"which":[375],"leads":[377,551],"control.":[381],"One":[382],"most":[385],"recommended":[386],"treatments":[388],"combination":[391],"calcipotriol,":[393],"vitamin":[395],"D":[396],"analog,":[397],"dipropionate,":[400],"corticosteroid,":[402],"(CAL/BDP).":[403],"Based":[404],"new":[407],"(PAD)":[410],"technology,":[411],"designed":[418],"make":[420],"easier":[422],"use,":[424],"more":[425],"cosmetically":[426],"acceptable,":[427],"effective,":[429,540],"while":[430,523],"maintaining":[431],"safety":[433],"tolerability":[435],"previous":[437],"formulations.":[438],"recent":[440],"study":[441,532],"(PRO-SCALP),":[442],"evaluating":[443],"psoriasis,":[451],"especially":[459],"(patients":[465],"followed":[467],"as":[470,562],"prescribed).":[471],"Hence,":[472],"this":[474,531],"subgroup":[475],"analysis,":[476],"compared.":[484],"groups":[486],"experienced":[487],"meaningful":[488],"improvements,":[489],"but":[490],"presented":[495],"stronger":[496],"itch":[499],"lesions,":[502],"preference":[507],"PAD-cream.":[510],"They":[511],"also":[512],"life":[519],"psychosocial":[521],"well-being,":[522],"sleep":[524],"similarly":[526],"across":[527],"groups.":[529],"Overall,":[530],"further":[533],"shows":[534],"an":[539],"user-friendly":[541],"demonstrates":[547],"outcomes,":[554],"underlining":[555],"role":[558],"following":[560],"prescribed":[563],"by":[564],"healthcare":[566],"professional":[567],"best":[570],"control":[571]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-08-10T00:00:00"}